Molecular Oncology
Volume 2, Issue 4 , Pages 327-339 , December 2008

CAMK1D amplification implicated in epithelial–mesenchymal transition in basal-like breast cancer

  • Anna Bergamaschi

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello, 0310 Oslo, Norway
    • Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
  • ,
  • Young H. Kim

      Affiliations

    • Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
  • ,
  • Kevin A. Kwei

      Affiliations

    • Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
  • ,
  • Yoon La Choi

      Affiliations

    • Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    • Department of Pathology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul 135-710, South Korea
  • ,
  • Melanie Bocanegra

      Affiliations

    • Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
  • ,
  • Anita Langerød

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello, 0310 Oslo, Norway
  • ,
  • Wonshik Han

      Affiliations

    • Cancer Research Institute and Department of Surgery, Seoul National University College of Medicine, Seoul 110-744, South Korea
  • ,
  • Dong-Young Noh

      Affiliations

    • Cancer Research Institute and Department of Surgery, Seoul National University College of Medicine, Seoul 110-744, South Korea
  • ,
  • David G. Huntsman

      Affiliations

    • Department of Pathology, University of British Columbia, and British Columbia Cancer Agency, Vancouver, British Columbia V5Z 4E6, Canada
  • ,
  • Stefanie S. Jeffrey

      Affiliations

    • Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA
  • ,
  • Anne-Lise Børresen-Dale

      Affiliations

    • Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello, 0310 Oslo, Norway
    • Faculty of Medicine, University of Oslo, 0316 Oslo, Norway
  • ,
  • Jonathan R. Pollack

      Affiliations

    • Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    • Corresponding Author InformationCorresponding author at: Department of Pathology, Stanford University, 269 Campus Drive, CCSR-3245A, Stanford, CA 94305-5176, USA. Tel.: +1 650 736 1987.

Received 15 August 2008 ,Accepted 17 September 2008.

References 

  1. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, Lonning PE, et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer. 2006;45:1033–1040
  2. Boecker W, Buerger H. Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif. 2003;36(Suppl. 1):73–84
  3. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492–2502
  4. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, et al Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006;10:529–541
  5. Demeter J, Beauheim C, Gollub J, Hernandez-Boussard T, Jin H, Maier D, et al The Stanford Microarray Database: implementation of new analysis tools and open source release of software. Nucleic Acids Res. 2007;35:D766–D770
  6. Geisler S, Lonning PE, Aas T, Johnsen H, Fluge O, Haugen DF, et al. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res. 2001;61:2505–2512
  7. Geisler S, Borresen-Dale AL, Johnsen H, Aas T, Geisler J, Akslen LA, et al. TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer. Clin. Cancer Res. 2003;9:5582–5588
  8. Herber B, Truss M, Beato M, Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 1994;9:1295–1304
  9. Hicks J, Krasnitz A, Lakshmi B, Navin NE, Riggs M, Leibu E, et al Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res. 2006;16:1465–1479
  10. Hook SS, Means AR. Ca(2+)/CaM-dependent kinases: from activation to function. Annu. Rev. Pharmacol. Toxicol. 2001;41:471–505
  11. Ishikawa Y, Tokumitsu H, Inuzuka H, Murata-Hori M, Hosoya H, Kobayashi R. Identification and characterization of novel components of a Ca2+/calmodulin-dependent protein kinase cascade in HeLa cells. FEBS Lett. 2003;550:57–63
  12. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J. Clin. 2007;57:43–66
  13. Kahl CR, Means AR. Regulation of cyclin D1/Cdk4 complexes by calcium/calmodulin-dependent protein kinase I. J. Biol. Chem. 2004;279:15411–15419
  14. Kapp AV, Jeffrey SS, Langerod A, Borresen-Dale AL, Han W, Noh DY, et al. Discovery and validation of breast cancer subtypes. BMC Genomics. 2006;7:231
  15. Kreike, B., van Kouwenhove, M., Horlings, H., Weigelt, B., Bartelink, H., Van de Vijver, M.J., 2007. Gene expression profiling and histopathological characterization of triple negative/basal-like breast carcinomas. Breast Cancer Res. 9, R65.
  16. Lai C, Horlings HH, van de Vijver MM, van Beers EH, Nederlof PM, Wessels LF, et al. SIRAC: supervised identification of regions of aberration in aCGH datasets. BMC Bioinform. 2007;8:422
  17. Langerod, A., Zhao, H., Borgan, O., Nesland, J.M., Bukholm, I.R., Ikdahl, T., Karesen, R., Borresen-Dale, A.L., Jeffrey, S.S., 2007. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res. 9, R30.
  18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–408
  19. Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum. Pathol. 2003;34:1001–1008
  20. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al Molecular portraits of human breast tumours. Nature. 2000;406:747–752
  21. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 1999;23:41–46
  22. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA. 2002;99:12963–12968
  23. Pruitt KD, Tatusova T, Maglott DR. NCBI reference sequence project: update and current status. Nucleic Acids Res. 2003;31:34–37
  24. Rodriguez-Mora OG, LaHair MM, McCubrey JA, Franklin RA. Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res. 2005;65:5408–5416
  25. Ross DT, Perou CM. A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines. Dis Markers. 2001;17:99–109
  26. Sawyers CL. Rational therapeutic intervention in cancer: kinases as drug targets. Curr. Opin. Genet. Dev. 2002;12:111–115
  27. Schuler GD. Pieces of the puzzle: expressed sequence tags and the catalog of human genes. J. Mol. Med. 1997;75:694–698
  28. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 1999;68:821–861
  29. Soderling TR. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem. Sci. 1999;24:232–236
  30. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA. 2001;98:10869–10874
  31. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA. 2003;100:8418–8423
  32. Subramaniam DS, Isaacs C. Utilizing prognostic and predictive factors in breast cancer. Curr. Treat. Options Oncol. 2005;6:147–159
  33. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545–15550
  34. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics. 2007;23(23):3251–3253
  35. Thiery JP. Epithelial–mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2002;2:442–454
  36. Thompson EW, Newgreen DF, Tarin D. Carcinoma invasion and metastasis: a role for epithelial–mesenchymal transition?. Cancer Res. 2005;65:5991–5995discussion 5995
  37. Verploegen S, Lammers JW, Koenderman L, Coffer PJ. Identification and characterization of CKLiK, a novel granulocyte Ca(++)/calmodulin-dependent kinase. Blood. 2000;96:3215–3223
  38. Verploegen S, Ulfman L, van Deutekom HW, van Aalst C, Honing H, Lammers JW, et al. Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function. Blood. 2005;106:1076–1083
  39. Wang P, Kim Y, Pollack J, Narasimhan B, Tibshirani R. A method for calling gains and losses in array CGH data. Biostatistics. 2005;6:45–58
  40. Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, et al Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell. 2004;15:2523–2536

PII: S1574-7891(08)00124-5

doi: 10.1016/j.molonc.2008.09.004

Molecular Oncology
Volume 2, Issue 4 , Pages 327-339 , December 2008